Dopamine agonist activity of EMD 23,448MARTIN, G. E; PETTIBONE, D. J.Journal of neural transmission. 1985, Vol 61, Num 1-2, pp 115-123, issn 0300-9564Article

Dopaminergic agents including 3-PPP and its enantiomers on medial septal self-stimulationGOWER, A. J; BROEKKAMP, C. L. E.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 2, pp 309-315, issn 0091-3057Article

Further studies on alterations in male rat copulatory behavior induced by the dopamine-receptor agonist RDS-127CLARK, J. T; STEFANICK, M. L; SMITH, E. R et al.Pharmacology, biochemistry and behavior. 1983, Vol 19, Num 5, pp 781-786, issn 0091-3057Article

Dopamine agonists in the treatment of dystoniaLANG, A. E.Clinical neuropharmacology. 1985, Vol 8, Num 1, pp 38-57, issn 0362-5664Article

Hemiparkinsonism-Hemiatrophy SyndromeAYROMLOU, Hormoz; NAJMI, Safa; MOHAMMAD ALI ARAMI et al.Archives of Iranian medicine. 2011, Vol 14, Num 2, pp 152-154, 3 p.Article

Dopamine receptors: applications in clinical cardiologyGOLDBERG, L. I; RAJFER, S. I.Circulation (New York, N.Y.). 1985, Vol 72, Num 2, pp 245-248, issn 0009-7322Article

Pharmacological characterization of apomorphine-induced hypothermia in the spontaneously hypertensive ratMARTIN, J. R; QUOCK, R. M.Life sciences (1973). 1984, Vol 35, Num 9, pp 929-936, issn 0024-3205Article

In-vitro and in-vivo metabolism of the presynaptic dopamine agonist 3-PPP to a catecholic analogue in ratsROLLEMA, H; MASTEBROEK, D; WIKSTROM, H et al.Journal of pharmacy and pharmacology. 1985, Vol 37, Num 5, pp 314-319, issn 0022-3573Article

Microbial transformations of pergolide to pergolide sulfoxide and pergolide sulfoneSMITH, R. V; DAVIS, P. J; KERR, K. M et al.Journal of pharmaceutical sciences. 1983, Vol 72, Num 7, pp 733-736, issn 0022-3549Article

Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in ratsPROTAIS, P; DUBUC, I; COSTENTIN, J et al.European journal of pharmacology. 1983, Vol 94, Num 3-4, pp 271-280, issn 0014-2999Article

Ha-117 and Ha-118 are potent dopamine receptor agonistsILHAN, M; LONG, J. P; CANNON, J. G et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 3, pp 213-214, issn 0022-3573Article

The interaction between metoclopramide and dopaminergic agonists at the level of sympathetic ganglionTUNCER, M.Archives internationales de physiologie et de biochimie. 1984, Vol 92, Num 3, pp 227-231, issn 0003-9799Article

In vivo and in vitro dopaminergic effects of three ergoline fragmentsKOONS, J. C; LONG, J. P; CANNON, J. G et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 2, pp 180-185, issn 0028-1298Article

Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrainBRADBURY, A. J; COSTALL, B; NAYLOR, R. J et al.Neuropharmacology. 1983, Vol 22, Num 10, pp 1171-1176, issn 0028-3908Article

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonistsWHITE, F. J; WANG, R. Y.Life sciences (1973). 1984, Vol 34, Num 12, pp 1161-1170, issn 0024-3205Article

Cardiac and Noncardiac Fibrotic Reactions Caused by Ergot-and Nonergot-Derived Dopamine AgonistsANDERSOHN, Frank; GARBE, Edeltraut.Movement disorders. 2009, Vol 24, Num 1, pp 129-133, issn 0885-3185, 5 p.Article

Factors determining the remission of microprolactinomas after dopamine agonist withdrawalHUDA, M. S. B; ATHAUDA, N. B; TEH, M. M et al.Clinical endocrinology (Oxford. Print). 2010, Vol 72, Num 4, pp 507-511, issn 0300-0664, 5 p.Article

Bromocriptine-responsive idiopathic edemaZIMLICHMAN, R. R; PORATH, A; SOBEL, R et al.Israel journal of medical sciences. 1984, Vol 20, Num 3, pp 264-266, issn 0021-2180Article

Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesiaWASZCZAK, B; EUN KYU LEE; FERRARO, T et al.Brain research. 1984, Vol 306, Num 1-2, pp 307-318, issn 0006-8993Article

Effect of apomorphine infusion on plasma homovanillic acid in normal subjectsDAVIDSON, M; KENDLER, K. S; MOHS, R. C et al.Journal of psychiatric research. 1986, Vol 20, Num 2, pp 131-135, issn 0022-3956Article

Intérêt du pergolide dans le traitement de la maladie de Parkinson = Pergolide in Parkinson diseaseBARROCHE, G; GEHIN, P; VESPIGNANI, H et al.Annales médicales de Nancy et de l'Est. 1984, Vol 23, pp 70-73, issn 0221-3796Article

Dopaminergic behaviour stereospecifically promoted by the D₁ agonist R-SK ] F 38393 and selectively blocked by the D₁ antagonist SCH 23390MOLLOY, A. G; WADDINGTON, J. L.Psychopharmacologia. 1984, Vol 82, Num 4, pp 409-410, issn 0033-3158Article

Effects of cholecystokinin on apomorphine induced changes of motility in ratsKATSUURA, G; ITOH, S; REHFELD, J. F et al.Neuropharmacology. 1984, Vol 23, Num 7A, pp 731-734, issn 0028-3908Article

The dopaminergic system in the peripherySCHWARTZ, J.Journal de pharmacologie. 1984, Vol 15, Num 4, pp 401-414, issn 0021-793XArticle

Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?FOWLER, C. J; THORELL, G; ANDERSSON, M et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 331, Num 1, pp 12-19, issn 0028-1298Article